Swiss National Bank’s ResMed RMD Stock Holding History

Swiss National Bank’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$96.2M	Buy	428,380 +28,760	+7%	+$7.17M	0.06%	283
2025 Q4	$96.3M	Sell	399,620 -23,080	-5%	-$5.9M	0.06%	270
2025 Q3	$116M	Sell	422,700 -21,900	-5%	-$5.98M	0.07%	249
2025 Q2	$115M	Buy	444,600 +30,500	+7%	+$7.28M	0.07%	250
2025 Q1	$92.7M	Sell	414,100 -500	-0.1%	-$117K	0.07%	263
2024 Q4	$94.8M	Sell	414,600 -21,500	-5%	-$5.18M	0.06%	262
2024 Q3	$106M	Buy	436,100 +600	+0.1%	+$134K	0.07%	257
2024 Q2	$83.4M	Sell	435,500 -5,000	-1%	-$1.01M	0.06%	291
2024 Q1	$87.2M	Sell	440,500 -19,400	-4%	-$3.55M	0.06%	291
2023 Q4	$79.1M	Sell	459,900 -12,700	-3%	-$1.95M	0.06%	304
2023 Q3	$69.9M	Sell	472,600 -57,900	-11%	-$10.5M	0.05%	318
2023 Q2	$116M	Sell	530,500 -50,900	-9%	-$11.3M	0.08%	243
2023 Q1	$127M	Sell	581,400 -13,700	-2%	-$2.97M	0.09%	229
2022 Q4	$124M	Sell	595,100 -38,431	-6%	-$8.44M	0.09%	230
2022 Q3	$138M	Sell	633,531 -800	-0.1%	-$182K	0.1%	203
2022 Q2	$133M	Buy	634,331 +3,200	+0.5%	+$681K	0.09%	211
2022 Q1	$153M	Buy	631,131 +77,400	+14%	+$18.7M	0.09%	221
2021 Q4	$144M	Sell	553,731 -21,600	-4%	-$5.6M	0.09%	218
2021 Q3	$152M	Sell	575,331 -17,500	-3%	-$4.79M	0.1%	199
2021 Q2	$146M	Buy	592,831 +35,760	+6%	+$7.52M	0.09%	218
2021 Q1	$108M	Buy	557,071 +9,600	+2%	+$1.93M	0.07%	280
2020 Q4	$116M	Sell	547,471 -15,700	-3%	-$3.13M	0.08%	240
2020 Q3	$96.5M	Sell	563,171 -8,900	-2%	-$1.64M	0.08%	258
2020 Q2	$110M	Buy	572,071 +14,000	+3%	+$2.29M	0.09%	204
2020 Q1	$82.2M	Buy	558,071 +105,100	+23%	+$16.7M	0.09%	219
2019 Q4	$70.2M	Sell	452,971 -20,500	-4%	-$2.95M	0.07%	287
2019 Q3	$64M	Buy	473,471 +6,471	+1%	+$848K	0.07%	304
2019 Q2	$57M	Sell	467,000 -8,700	-2%	-$964K	0.06%	325
2019 Q1	$49.5M	Buy	475,700 +11,500	+2%	+$1.19M	0.05%	350
2018 Q4	$52.9M	Buy	464,200 +8,600	+2%	+$921K	0.07%	290
2018 Q3	$52.5M	Sell	455,600 -16,400	-3%	-$1.8M	0.06%	336
2018 Q2	$48.9M	Buy	472,000 +17,600	+4%	+$1.78M	0.06%	355
2018 Q1	$44.7M	Sell	454,400 -68,000	-13%	-$6.43M	0.05%	371
2017 Q4	$44.2M	Sell	522,400 -76,800	-13%	-$6.34M	0.05%	409
2017 Q3	$46.1M	Buy	599,200 +6,800	+1%	+$520K	0.05%	376
2017 Q2	$46.1M	Buy	592,400 +17,100	+3%	+$1.22M	0.05%	371
2017 Q1	$41.4M	Buy	575,300 +113,900	+25%	+$7.87M	0.05%	390
2016 Q4	$28.6M	Buy	461,400 +73,100	+19%	+$4.48M	0.05%	428
2016 Q3	$25.2M	Sell	388,300 -4,100	-1%	-$273K	0.04%	451
2016 Q2	$24.8M	Buy	392,400 +29,700	+8%	+$1.75M	0.04%	455
2016 Q1	$20.1M	Buy	362,700 +108,300	+43%	+$6.13M	0.04%	480
2015 Q4	$13.7M	Buy	254,400 +2,900	+1%	+$163K	0.03%	497
2015 Q3	$12.8M	Buy	251,500 +25,000	+11%	+$1.35M	0.03%	497
2015 Q2	$12.8M	Buy	226,500 +14,100	+7%	+$890K	0.03%	517
2015 Q1	$15.2M	Buy	212,400 +82,300	+63%	+$5.35M	0.04%	447
2014 Q4	$7.29M	Sell	130,100 -4,800	-4%	-$251K	0.03%	538
2014 Q3	$6.65M	Sell	134,900 -3,200	-2%	-$163K	0.03%	562
2014 Q2	$6.99M	Buy	138,100 +100	+0.1%	+$4.96K	0.03%	565
2014 Q1	$6.17M	Sell	138,000 -13,000	-9%	-$584K	0.02%	595
2013 Q4	$7.11M	Sell	151,000 -3,300	-2%	-$167K	0.03%	534
2013 Q3	$8.15M	Buy	154,300 +1,600	+1%	+$77.6K	0.03%	482
2013 Q2	$6.89M	Buy	+152,700	New	+$7.25M	0.03%	502

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Swiss National Bank's RMD Position: Q1 2026 in Review

Swiss National Bank increased its ResMed (RMD) stake by 7.2% in Q1 2026, buying an estimated $7.17M and bringing the position to 428,380 shares worth $96.2M. The position accounts for 0.06% of the portfolio, ranked #283.

Swiss National Bank first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $153M in Q1 2022. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Swiss National Bank held 428,380 shares of ResMed worth $96.2M as of Q1 2026.
Swiss National Bank bought 28,760 ResMed shares in Q1 2026, an estimated $7.17M.
ResMed made up 0.06% of Swiss National Bank's portfolio in Q1 2026, its #283 holding.
Swiss National Bank first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
Swiss National Bank's ResMed position peaked at $153M in Q1 2022.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.